"Inside the explosive rise of a wellness company outpacing a $200B+ global market"Watch the full Morning Show interview → ...

US agreement removes U.S. tariffs on UK drugs but requires the NHS to pay more for new medicines by raising NICE thresholds ...

Phase 1 results show that SUL-238 is safe, well-tolerated, and demonstrates favorable pharmacokinetics with high CSF ...

SIOUX FALLS, SD / ACCESS Newswire / December 2, 2025 / Avel eCare is pleased to announce the appointment of Pat Gundersen as its new Chief Revenue Officer, bringing more than twenty years of ...

Funds will enable launch of AI-powered R&D center and bring BiPER Tx’s selective BiP (GRP78) inhibitor clinical candidate BPR001-615 a step closer to entering phase 1/2a clinical trial in ...

Ideagen's CEO explains why binary outcomes and high stakes make compliance ideal for autonomous AINOTTINGHAM, ...

This is the first agreement signed by the EIB with a corporate venture capital in the healthcare sector, and is part of the EU strategy to support the development of innovative companies across the ...

IonQ serves as strategic quantum technology partner across CCRM’s leading global regenerative medicine network COLLEGE PARK, MD – December 1, 2025 - IonQ (NYSE: IONQ), the world’s leading quantum ...

SOBIN-AD Also Reduces Aβ Plaque Formation and Synaptophysin Loss in Asymptomatic Disease in a Preclinical ...

AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, ...

Sound Pharmaceuticals (SPI) is pleased to announce that the FDA has granted its investigational new drug, SPI-1005, ...

New analyses from the ongoing open label extension (OLE) studies and findings from electroencephalogram (EEG) assessments in ...